{"id":"W2793884909","doi":"10.1016/j.cmi.2018.01.002","title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","year":2018,"lang":"en","type":"article","venue":"Clinical Microbiology and Infection","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1518,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Institute of Infection and Immunity","funders":"Medical Research Council; Centre Hospitalier Universitaire Vaudois; Amplyx; Actelion Pharmaceuticals; European Society of Clinical Microbiology and Infectious Diseases; Cidara Therapeutics; Wellcome Trust; Duke University","keywords":"Posaconazole; Medicine; Voriconazole; Guideline; Intensive care medicine; Bronchoalveolar lavage; Aspergillosis; Caspofungin; Internal medicine; Pathology; Immunology; Dermatology; Antifungal; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}